Skip to Main content Skip to Navigation
Journal articles

Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study

Abstract : Purposes: Following a hospitalization for COPD, dual and triple therapies were compared in terms of persistence and relations with outcomes (exacerbations, health care resource use and costs). Methods: This was a historical observational database study. All patients aged ≥45 hospitalized for COPD between 2007 and 2015 were identified in a 1/97 th random sample of French claims data. Patients receiving dual therapy within 60 days after hospitalization were compared to patients receiving triple therapy, after propensity score matching on disease severity. Results: Of the 3,089 patients hospitalized for COPD, 1,538 (49.8%) received either dual or triple therapy in the 2 months following inclusion, and 1,500 (48.6%) had at least 30 days of follow-up available; 846 (27.4%) received dual therapy, and 654 (21.2%) received triple therapy. After matching, the number of exacerbations was 2.4 per year in the dual vs 2.3 in the triple group (p=0.45). Among newly treated patients (n=206), persistence at 12 months was similar in the dual and triple groups (48% vs 41%, respectively, p=0.37). As compared to patients on dual therapy, more patients on triple therapy received oral corticosteroids (49.1 vs 40.4%, p=0.003) or were hospitalized for any reason (67% vs 55.8%, p=0.0001) or for COPD (35.3 vs 25.1%, p=0.0002) during follow-up. Cost of care was higher for patients on triple than for those on dual therapy (€11,877.1 vs €9,825.1, p=0.01). Conclusion: Following hospitalizations for COPD, patients on dual and triple therapy experienced recurrent exacerbations, limited adherence to therapies and high cost of care. Patients on triple therapy appeared more severe than those on dual therapy, as reflected by exacerbations and health care resource use.
Document type :
Journal articles
Complete list of metadatas

Cited literature [49 references]  Display  Hide  Download

https://hal.univ-reims.fr/hal-02448839
Contributor : Valerian Dormoy <>
Submitted on : Friday, May 29, 2020 - 3:47:01 PM
Last modification on : Thursday, June 11, 2020 - 4:39:14 AM

File

DalonFaustine_IntJCOPD_2019.pd...
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Faustine Dalon, Nicolas Roche, Manon Belhassen, Maeva Nolin, Hervé Pegliasco, et al.. Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study. International Journal of Chronic Obstructive Pulmonary Disease, Dove Medical Press, 2019, Volume 14, pp.1839-1854. ⟨10.2147/COPD.S214061⟩. ⟨hal-02448839⟩

Share

Metrics

Record views

57

Files downloads

30